Reticulosis and reticulosarcoma associated with leukaemia have been dealt with in a number of publications during recent decades. In 1928 Richter observed the coexistence of regional reticulosarcoma and lymphatic leukaemia. Tumour-like hyperplasia of the reticulo-endothelial system with leukaemia was described in 1932 by Loesch. Similar observations have been reported concerning myeloid leukaemia (Introzzi, 1955; Belolipetskia and Gets, 1960; Luscher, 1960; Garbsch, Peschl, Reimer, Simon, and Zeitlhofer, 1963) . Some authors postulated a direct casual relationship between cytostatic therapy and tumour-like reticulosis (Chiari, 1964; Fritsch, 1964) .
In our cases granulomatous giant cell reticulosis similar in appearance to Hodgkin's The patient died two years after the first admission in 1964.
The following is an extract from the necropsy report (Dote 256/64). Gross findings correspond to lymphatic leukaemia. Generalized lymph node enlargement, hepatosplenomegaly, and secondary anaemia were evident.
Histological findings The normal architecture of the cervical, supraclavicular, and axillary lymph nodes is lost. The nodes are infiltrated by leukaemic cells and, in addition, polymorphic reticulum cell proliferation is seen in large foci (Fig. 1) , which are characterized by reticulum cells with pale nuclei (some with pyknotic ones), 'mirror image' cells ( Fig. 2) , multinucleated cells with an average size of 40 i resembling those of ReedSternberg type (Fig. 3) 
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The diagnosis is chronic myeloid leukaemia. In addition to leukaemic infiltration there is a focal giant cell reticulosis resembling lymphogranulomatosis in the inguinal, paraaortal, and pelvic lymph nodes.
DISCUSSION
The following four relationships may exist between lymph node tumours and the leukaemias. (1) The leukaemic phase occurs in the course of malignant neoplastic lymph node diseases, and is represented either by lymphoid leukaemic transformation of lymphosarcoma or by a histiocyte-leukaemic change in reticulosarcoma. (2) Malignant lymph node tumour and leukaemia exist simultaneously. The coexistence of Hlodgkin's disease and leukaemia also belongs to this category (Seife, Reich, and Lisa, 1951; Krim, Meyer, Rosenthal, and Ritz, 1952; Samwick, Cohn, and Swiller, 1955; Epstein, 1956; Keiser, Uehlinger, and Virieux, 1961; Lacher and Sussman, 1963; Guichard, Vauzelle, and Roachet, 1964) . (3) Leukaemia associated with reticulosarcoma forms the third group. (4) Leukaemia may be associated with a non-neoplastic reactive reticulosis. As a rule the diagnosis is established in this category by post-mortem examination. The transformation possibly develops in the final stage of leukaemia, which is why it is often referred to as terminal reticulosis, although its terminal occurrence has not been proved. Only the histological study of repeated lymph node biopsies could form a sufficient basis for a definite conclusion. But removal of lymph nodes from diagnosed leukaemic patients is not accepted as standard practice. Hence the terminal character of the transformation is doubtful.
The lesion is correlated with cytostatic therapy. Fritsch (1964) suggests that the cytostatics and x-ray treatment may exert a direct effect or an indirect effect upon the reticulo-endothelial system, i.e., substances from destroyed cells are responsible for the proliferation, or even that the reactive reticulosis is due to the prolonged disease process. In addition Fritsch postulates a common aetiological factor which affects the haemopoietic tissue and reticulo-endothelial system alike. In opposition to this view Chiari (1964) claims that the source of this peculiar cell proliferation is the haemocytoblasts.
Our cases can be fitted into the fourth group. The granulomatous giant cell proliferation affected the lymph nodes exclusively, and similar changes in the spleen, bone marrow, and liver were not detected. These polymorphic cells are not consistent with degenerated leukaemic elements because (1) phagocytosis, lipid storage, and mitotic activity are rarely seen in degenerated cells; (2) the foci are separated from the adjacent leukaemic cells.
The non-megakaryocyte origin of multinucleated cells is supported by their absence in the spleen. Also in our case of lymphatic leukaemia a considerable number of giant cells were observed, while signs of myeloid metaplasia in the neighbourhood of multinucleated cells were lacking. Hence we do not consider these mutinucleated cells megakaryocytes inherent in metaplastic erythromyelopoesis.
In both cases the histological picture resembles Hodgkin's disease from many points of view. The focal granulomatous reticulum cell proliferation was confined to the lymph nodes. The large reticulum cells resembled Hodgkin cells. 'Mirror image' cells, infiltration by eosinophils, necrosis, and fibrosis were present.
The histological picture also suggests two theoretical explanations. Conceivably the leukaemia and Hodgkin's disease coexisted as two separate diseases. If so the possibility of a common aetiology and pathogenesis is logical, although such a connexion between. the two pathological processes has not been substantiated by previous lymph node examinations.
The most plausible explanation is that a reactive non-neoplastic reticulosis, very similar in appearance to Hodgkin's disease, developed in the terminal phase of leukaemia due to cytostatic therapy.
Repeatedly performed lymph node biopsies in leukaemic cases would enable further clarification of this process.
